LMWH is indicated in neonates for both the prevention and treatment of venous thromboembolism (VTE). This includes conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE). Additionally, it is used in neonates with central venous catheters to prevent catheter-related thrombosis, and in those with congenital heart defects to prevent thrombus formation.
